Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000670676 | SCV000795562 | uncertain significance | Fanconi anemia complementation group A | 2017-11-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001204945 | SCV001376177 | pathogenic | Fanconi anemia | 2022-08-16 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 8 of the FANCA gene. It does not directly change the encoded amino acid sequence of the FANCA protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (rs749688050, gnomAD 0.003%). For these reasons, this variant has been classified as Pathogenic. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 554952). This variant has been observed in individual(s) with clinical features of Fanconi anemia (PMID: 25239263; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. |
Leiden Open Variation Database | RCV000670676 | SCV001425768 | uncertain significance | Fanconi anemia complementation group A | 2020-02-28 | no assertion criteria provided | curation | Curator: Arleen D. Auerbach. Submitter to LOVD: Arleen D. Auerbach. |